Education
About Us
Working with TipRanks
Follow Us
AVIE - ETF AI Analysis
Top Page
Avantis Inflation Focused Equity ETF (AVIE)
Rating:71Outperform
Price Target:―
Positive Factors
Strong Top Holdings
Several key holdings, such as Johnson & Johnson and Philip Morris, have delivered strong year-to-date performance, supporting the ETF's overall returns.
Sector Diversification
The ETF is spread across multiple sectors like Health Care, Energy, and Consumer Defensive, reducing reliance on any single industry.
Low Expense Ratio
With a competitive expense ratio of 0.25%, this ETF offers cost-efficient exposure compared to many similar funds.
Negative Factors
Over-Concentration in U.S. Market
The ETF has over 99% exposure to U.S. companies, limiting diversification across global markets.
Underperforming Holdings
Some top holdings, like Procter & Gamble and UnitedHealth, have lagged in performance, potentially dragging down returns.
Sector Imbalance
The ETF is heavily weighted toward Health Care and Energy, which may increase vulnerability to sector-specific risks.
AVIE Historical Chart
AUM6.55M
RegionNorth America
Expense Ratio0.25%
Beta0.50
IssuerAvantis
Inception DateSep 27, 2022
Dividend Yield1.76%
Asset ClassEquity
Index TrackedNo Underlying Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume294
30 Day Avg. Volume367
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
74.26Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering350
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
AVIE Summary
The Avantis Inflation Focused Equity ETF (AVIE) is designed for investors who want to protect their money from inflation while investing in a wide range of companies across different sectors. This ETF includes large, mid, and small-cap stocks, with a focus on companies that can perform well during inflationary periods, such as Berkshire Hathaway and Exxon Mobil. It’s a great option for those seeking diversification and a strategy that considers inflation risks. However, new investors should know that the ETF’s performance can fluctuate with the overall market, and its focus on inflation-conscious companies may limit exposure to high-growth sectors like technology.
How much will it cost me?The Avantis Inflation Focused Equity ETF (AVIE) has an expense ratio of 0.25%, which means you’ll pay $2.50 per year for every $1,000 invested. This cost is lower than average for actively managed ETFs because it focuses on inflation-conscious equity investments while maintaining broad market exposure.
What would affect this ETF?The Avantis Inflation Focused Equity ETF (AVIE) could benefit from rising inflation, as its focus on companies with strong pricing power and fundamentals may help it perform well in such environments. Positive trends in sectors like Health Care and Energy, which make up a significant portion of its holdings, could also drive growth. However, economic slowdowns or regulatory changes affecting key sectors like Energy or Financials, as well as declining inflation concerns, could negatively impact its performance.
AVIE Top 10 Holdings
The Avantis Inflation Focused Equity ETF (AVIE) leans heavily into health care and energy, with names like Eli Lilly and Exxon Mobil driving much of the fund’s recent momentum. Eli Lilly’s rising performance, fueled by strong revenue growth and pipeline advancements, stands out as a key contributor, while Exxon Mobil’s steady gains reflect its operational strength amid inflationary pressures. However, consumer-focused stocks like Procter & Gamble and PepsiCo are lagging, holding back broader performance. With a U.S.-centric portfolio and a focus on inflation-ready sectors, AVIE offers a strategic hedge but faces mixed results from its defensive holdings.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Berkshire Hathaway B | 6.98% | $458.89K | $1.09T | 12.03% | 66 Neutral | |
| Exxon Mobil | 5.15% | $338.73K | $495.14B | 10.45% | 74 Outperform | |
| Eli Lilly & Co | 4.42% | $290.66K | $984.89B | 39.51% | 72 Outperform | |
| Procter & Gamble | 3.60% | $236.79K | $345.39B | -13.99% | 69 Neutral | |
| Chevron | 2.73% | $179.42K | $301.06B | 4.63% | 71 Outperform | |
| AbbVie | 2.60% | $170.92K | $396.44B | 29.91% | 66 Neutral | |
| Johnson & Johnson | 2.26% | $148.49K | $506.75B | 45.08% | 78 Outperform | |
| UnitedHealth | 2.25% | $148.24K | $300.40B | -32.93% | 72 Outperform | |
| Philip Morris | 2.15% | $141.64K | $246.90B | 28.76% | 61 Neutral | |
| PepsiCo | 2.13% | $139.87K | $205.21B | -1.39% | 78 Outperform |
AVIE Technical Analysis
Neutral
―
Price Trends
63.97
Positive
62.70
Positive
61.58
Positive
Market Momentum
0.40
Positive
53.08
Neutral
29.06
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For AVIE, the sentiment is Neutral. The current price of undefined is equal to the 20-day moving average (MA) of 65.24, equal to the 50-day MA of 63.97, and equal to the 200-day MA of 61.58, indicating a neutral trend. The MACD of 0.40 indicates Positive momentum. The RSI at 53.08 is Neutral, neither overbought nor oversold. The STOCH value of 29.06 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for AVIE.
AVIE Peer Comparison
Comparison Results
Performance Comparison
AVIE
Avantis Inflation Focused Equity ETF
65.19
6.59
11.25%
YALL
God Bless America ETF
―
―
―
BAMD
Brookstone Dividend Stock ETF
―
―
―
STNC
Stance Equity ESG Large Cap Core ETF
―
―
―
RFDA
RiverFront Dynamic US Dividend Advantage ETF
―
―
―
STOX
Horizon Core Equity ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents